CDC Report: Rising Drug-Resistant Bacteria Threat
- This report summarizes key facts regarding the recent surge in NDM-producing carbapenem-resistant Enterobacterales (NDM-CRE), based on details from the CDC.
- * Dramatic Increase: NDM-CRE infections have surged by more than 460% in the United States between 2019 and 2023.
- * CRE Overview: NDM-CRE is a type of carbapenem-resistant Enterobacterales (CRE), which are already resistant to some of the strongest antibiotics.
FINAL SELF-CHECK (HARD STOP) – NDM-CRE Surge
Table of Contents
This report summarizes key facts regarding the recent surge in NDM-producing carbapenem-resistant Enterobacterales (NDM-CRE), based on details from the CDC.
Key Findings:
* Dramatic Increase: NDM-CRE infections have surged by more than 460% in the United States between 2019 and 2023.
* Arduous to Treat: NDM-CRE are resistant to many, and frequently enough nearly all, available antibiotics due to the New Delhi metallo-β-lactamase (NDM) enzyme.
* Serious risk: Infections (pneumonia, bloodstream, urinary tract, wound) are associated with high rates of morbidity and mortality.
* Detection Challenges: many clinical laboratories lack the necessary testing capacity to detect NDM-CRE.
* Potential for Spread: NDM-CRE can spread quickly through healthcare settings and into the community without proper infection control.
Background & Context:
* CRE Overview: NDM-CRE is a type of carbapenem-resistant Enterobacterales (CRE), which are already resistant to some of the strongest antibiotics.
* Pre-existing CRE Burden: In 2020, there were approximately 12,700 infections and 1,100 deaths in the U.S. due to CRE. The rise in NDM-CRE threatens to increase these numbers.
* Contributing Factors: The exact reasons for the surge are still being studied, but gaps in infection control are considered a contributing factor.
Data summary:
| Metric | 2019 | 2023 | Change (%) |
|---|---|---|---|
| NDM-CRE Infections | Baseline | Significantly Increased | >460% |
| 2020 CRE Infections | 12,700 | N/A | N/A |
| 2020 CRE Deaths | 1,100 | N/A | N/A |
Why This Matters:
* treatment Complexity: Selecting the right treatment is increasingly intricate, requiring access to testing for targeted therapies.
* Diagnostic Challenges: healthcare providers may not suspect NDM-CRE, leading to ineffective treatment choices.
* Public Health Threat: The rise in NDM-CRE represents a growing threat to the ability to treat serious bacterial infections.
Infection Control Measures (importent for Prevention):
* Hand Hygiene
* Gloves and gown during patient care
* Proper cleaning and disinfection